Zacks Adds Coinbase, Astellas Pharma, and McEwen to Strong Sell List

Zacks Investment Research··USJP·Read original
2▲0 ▼3Impact / 5
Summary · why it matters

Zacks Investment Research added Coinbase Global, Astellas Pharma, and McEwen to its Rank 5 Strong Sell list on August 6. The Zacks Consensus Estimate for Coinbase's current-year earnings has been revised 81.6% downward over the last 60 days. Astellas Pharma's current-year earnings estimate has been revised nearly 6% downward over the same period. McEwen's current-year earnings estimate has been revised 4.7% downward over the last 60 days.

Impact on assets 3

Biotech & Genomic Medicine▼ · 1 stocks
Astellas Pharma Inc.
4503
▼ NegativeCapitalrelevance

Zacks added Astellas Pharma to Strong Sell list due to nearly 6% downward revision in current-year earnings estimate.

Digital Finance & Tokenization▼ · 1 stocks
Coinbase Global Inc
COIN
▼ NegativeCapitalrelevance

Zacks added Coinbase to Strong Sell list due to 81.6% downward revision in current-year earnings estimate.

Critical Materials & Supply Chain▼ · 1 stocks
McEwen Mining Inc.
MUX
▼ NegativeCapitalrelevance

Zacks added McEwen to Strong Sell list due to 4.7% downward revision in current-year earnings estimate.

© 2026 MarketIVNews